BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30696948)

  • 1. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.
    Rack KA; van den Berg E; Haferlach C; Beverloo HB; Costa D; Espinet B; Foot N; Jeffries S; Martin K; O'Connor S; Schoumans J; Talley P; Telford N; Stioui S; Zemanova Z; Hastings RJ
    Leukemia; 2019 Aug; 33(8):1851-1867. PubMed ID: 30696948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
    Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
    Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics in the genomic era.
    Granada I; Palomo L; Ruiz-Xivillé N; Mallo M; Solé F
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101196. PubMed ID: 33038985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'.
    Bentz M; Döhner H; Cabot G; Lichter P
    Leukemia; 1994 Sep; 8(9):1447-52. PubMed ID: 8090024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.
    Clin Adv Hematol Oncol; 2005 Mar; 3(3 Suppl 1):1-10; quiz 11-2. PubMed ID: 21438190
    [No Abstract]   [Full Text] [Related]  

  • 7. Real-time quantitation of bcr-abl transcripts in haematological malignancies.
    Saffroy R; Lemoine A; Brézillon P; Frénoy N; Delmas B; Goldschmidt E; Souleau B; Nedellec G; Debuire B
    Eur J Haematol; 2000 Oct; 65(4):258-66. PubMed ID: 11073166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
    Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
    Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.
    Dewald GW
    Int J Hematol; 2002 Aug; 76 Suppl 2():65-74. PubMed ID: 12430903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Programs for continuing medical education: B session 7. Progress in treatment for hematologic diseases].
    Higashihara M
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):717-23. PubMed ID: 24796142
    [No Abstract]   [Full Text] [Related]  

  • 11. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA; Ferguson W; Mark HF
    Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
    Chen Z; Sandberg AA
    Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.
    Struski S; Luquet I
    Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNAs in myeloid malignancies.
    Gordon JE; Wong JJ; Rasko JE
    Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation in hematologic malignancy.
    Archuleta TD; Devetten MP; Armitage JO
    Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligo-based High-resolution aCGH Analysis Enhances Routine Cytogenetic Diagnostics in Haematological Malignancies.
    Kjeldsen E
    Cancer Genomics Proteomics; 2015; 12(6):301-37. PubMed ID: 26543079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome].
    Hernández JM; Granada I; Solé F;
    Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of recurrent cytogenetic abnormalities in acute lymphoblastic and myeloid leukemias using fluorescence in situ hybridization.
    Vance GH
    Methods Mol Biol; 2013; 999():79-91. PubMed ID: 23666691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
    Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
    Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of BRAF V600E mutation in hematologic malignancies excluding hairy-cell leukemia.
    Ping N; Wang Q; Wang Q; Dong S; Wu L; Xue Y; Ruan C; Wu D; Chen S
    Leuk Lymphoma; 2012 Dec; 53(12):2498-9. PubMed ID: 22639828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.